1262132-95-5

Basic information

• Product Name: tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate
• Synonyms: tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate
• CAS NO: 1262132-95-5
• Molecular Weight: 325.367
• Mol File: 1262132-95-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate(1262132-95-5)
• EPA Substance Registry System: tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate(1262132-95-5)

Safety Data

• Hazardous Substances Data: 1262132-95-5(Hazardous Substances Data)

Upstream product

• 1262132-93-3 tert-butyl 4-(benzyloxy)-2-chloronicotinate 
• 1262132-92-2 tert-butyl 2,4-dichloronicotinate 
• 1262132-94-4 tert-butyl 4-(benzyloxy)-2-hydrazinylnicotinate 
• 149-73-5 trimethyl orthoformate 
• 26452-80-2 2,4-dichloropyridine 
• 262423-77-8 2,4-dichloronicotinic acid 

Downstream Products

• 1262132-85-3 {[5-(4-fluoro-3-trifluoromethylphenyl)-7-hydroxy[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]amino}acetic acid 
• 1262132-97-7 tert-butyl 7-(benzyloxy)-5-iodo-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262132-98-8 C₂₅H₂₁F₄N₃O₃ 
• 1262132-99-9 C₂₁H₁₃F₄N₃O₃ 
• 1262133-00-5 C₂₅H₂₀F₄N₄O₄ 
• 1262133-01-6 C₁₈H₁₄F₄N₄O₄ 
• 1262133-02-7 tert-butyl 7-(benzyloxy)-5-(phenylethynyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262133-03-8 C₂₂H₁₅N₃O₃ 
• 1262133-07-2 tert-butyl 7-(benzyloxy)-5-butyl-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262132-96-6 tert-butyl 7-(benzyloxy)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylate 
• 1262132-05-7 (5-(3-chlorophenyl)-7-hydroxy-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)glycine 
• 1262133-44-7 tert-butyl (7-(benzyloxy)-[1,2,4]triazolo[4,3-a]pyridine-8-carbonyl)glycinate 
• 1262132-81-9 2-({[7-hydroxy-5-(2-phenylethyl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl]carbonyl}amino)acetic acid 

Relevant articles and documents

Fused ring heteroaryl derivative as well as pharmaceutical composition and treatment method and application thereof

The present invention relates to a fused ring heteroaryl derivative represented by formula (I) or a tautomer thereof. Use HIF of an optical isomer, an oxynitride, a solvate, or a pharmaceutically acceptable salt or prodrug thereof, for the treatment or al

TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT

The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.